Indian Researchers Develop Nanozymes That Can Block HIV Reactivation
1 Mins read
Reading Time: < 1 minuteAnti-HIV drugs are only successful in suppressing the virus; they fail at eradicating HIV from infected cells. Read More
No ARVs, please save our people from dying, Nyanza MPs appeal to Uhuru
1 Mins read
Reading Time: < 1 minuteA section of Nyanza MPs has appealed to President Uhuru Kenyatta to intervene in the standoff between the government and the USAID…
Getting to the core of HIV replication
1 Mins read
Reading Time: < 1 minuteViruses lurk in the gray area between the living and the nonliving, according to scientists. Read More
$29 Billion A Year By 2025 Needed To Get Back On Track To Tackle AIDS, Say UNAIDS
1 Mins read
Reading Time: < 1 minuteA new report from the UN agency dedicated to ending HIV and AIDS ( UNAIDS) has shown that investing $29 billion a year to…
Diabetes drug may be a new weapon against HIV
1 Mins read
Reading Time: < 1 minuteA team led by scientists at the UNC School of Medicine discovered an important vulnerability of the AIDS-causing retrovirus HIV, Read More
FG laments multi-drug resistant, HIV-associated TB in Nigeria
1 Mins read
Reading Time: < 1 minuteThe Federal Government has expressed concern that Nigeria is on the list of 14 countries with triple burden of tuberculosis (TB), human…
Kenya: Doctors in Homa Bay Raise Alarm Over Shortage of ARVs
1 Mins read
Reading Time: < 1 minuteMore than 114,000 people living with HIV in Homa Bay County are facing an uncertain future following delays in delivery of antiretroviral…
Sex workers contributed 6.9% to new HIV infections
1 Mins read
Reading Time: < 1 minuteThere are around 150,000 sex workers in South Africa. The National Strategic Plan on HIV identifies sex workers as a “key population” at high risk…
Women living with HIV continue the fight against forced sterilisation
1 Mins read
Reading Time: < 1 minuteWomen living with HIV demand justice — and autonomy over their bodies. Read More
Vaccine regimen fails to prevent HIV-1 infection in South Africa
1 Mins read
Reading Time: < 1 minuteA canarypox-protein HIV vaccine regimen (ALVAC-HIV) plus bivalent subtype C gp120-MF59 adjuvant does not prevent HIV-1 infection among adults in South Africa, …